Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Total Liabilities: 2020-2025

Historic Total Liabilities for iSpecimen (ISPC) over the last 5 years, with Sep 2025 value amounting to $5.9 million.

  • iSpecimen's Total Liabilities fell 9.54% to $5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.9 million, marking a year-over-year decrease of 9.54%. This contributed to the annual value of $6.0 million for FY2024, which is 0.64% down from last year.
  • iSpecimen's Total Liabilities amounted to $5.9 million in Q3 2025, which was up 9.47% from $5.4 million recorded in Q2 2025.
  • In the past 5 years, iSpecimen's Total Liabilities ranged from a high of $8.9 million in Q2 2021 and a low of $2.9 million during Q2 2023.
  • In the last 3 years, iSpecimen's Total Liabilities had a median value of $5.7 million in 2024 and averaged $5.2 million.
  • Its Total Liabilities has fluctuated over the past 5 years, first tumbled by 73.43% in 2021, then skyrocketed by 103.25% in 2024.
  • Quarterly analysis of 5 years shows iSpecimen's Total Liabilities stood at $5.9 million in 2021, then declined by 27.32% to $4.3 million in 2022, then skyrocketed by 41.07% to $6.1 million in 2023, then dropped by 0.64% to $6.0 million in 2024, then dropped by 9.54% to $5.9 million in 2025.
  • Its Total Liabilities stands at $5.9 million for Q3 2025, versus $5.4 million for Q2 2025 and $5.2 million for Q1 2025.